BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35817068)

  • 1. Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B.
    Mohareb AM; Larmarange J; Kim AY; Coffie PA; Kouamé MG; Boyd A; Freedberg KA; Hyle EP
    Lancet HIV; 2022 Aug; 9(8):e585-e594. PubMed ID: 35817068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?
    Mohareb AM; Kouamé MG; Nouaman M; Kim AY; Larmarange J; Neilan AM; Lacombe K; Freedberg KA; Boyd A; Coffie P; Hyle EP
    J Int AIDS Soc; 2024 Mar; 27(3):e26218. PubMed ID: 38444112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out.
    Joseph Davey D; Hsiao NY; Wendy Spearman C; Sonderup M; Hu NC; Mashele N; Mvududu R; Myer L
    BMC Infect Dis; 2022 Sep; 22(1):719. PubMed ID: 36050648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
    Solomon MM; Schechter M; Liu AY; McMahan VM; Guanira JV; Hance RJ; Chariyalertsak S; Mayer KH; Grant RM;
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):281-6. PubMed ID: 26413853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis.
    Baxter C; Ngcapu S; Blackard JT; Powell EA; Penton PK; Abdool Karim SS
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31248149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
    Buzo BF; Ramos JF; Marques Rossetti RA; Salles N; Mendrone-Júnior A; Rocha V; de Seixas Santos Nastri AC
    Transpl Infect Dis; 2020 Apr; 22(2):e13243. PubMed ID: 31901206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report.
    Malahleha M; Ahmed K; Deese J; Nanda K; van Damme L; De Baetselier I; Burnett RJ
    J Med Case Rep; 2015 Sep; 9():207. PubMed ID: 26411737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult hepatitis B and HIV infection.
    Soriano V; Aguilera A; Gonzalez R; Gomez-Gallego F; Barea L; Treviño M; Corral O
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1403-1407. PubMed ID: 30969194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
    Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
    Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.
    Mo YQ; Liang AQ; Ma JD; Chen LF; Zheng DH; Schumacher HR; Dai L
    BMC Musculoskelet Disord; 2014 Dec; 15():449. PubMed ID: 25532827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the Hepatitis B Virus/HIV-Coinfected Patient.
    Sherman KE
    Top Antivir Med; 2015; 23(3):111-4. PubMed ID: 26518394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
    Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
    World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204.
    Hwang JP; Arnold KB; Unger JM; Chugh R; Tincopa MA; Loomba R; Hershman D; Ramsey SD
    Support Care Cancer; 2022 Dec; 31(1):93. PubMed ID: 36585488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis.
    Ding ZN; Meng GX; Xue JS; Yan LJ; Liu H; Yan YC; Chen ZQ; Hong JG; Wang DX; Dong ZR; Li T
    J Cancer Res Clin Oncol; 2023 May; 149(5):1993-2008. PubMed ID: 35767193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
    Kohrt HE; Ouyang DL; Keeffe EB
    Clin Liver Dis; 2007 Nov; 11(4):965-91, x. PubMed ID: 17981237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy.
    Chang WY; Chiu YC; Chiu FW; Hsu YC; Tseng TC; Cheng PN; Yang SS; Liu CJ; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2020 Sep; 222(8):1345-1352. PubMed ID: 32396638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.
    Plaza Z; Aguilera A; Mena A; Vispo E; Sierra-Enguita R; Tomé S; Pedreira J; Rodriguez C; Barreiro P; del Romero J; Soriano V; Poveda E
    AIDS; 2013 Sep; 27(14):2219-24. PubMed ID: 23669158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral hepatitis in persons living with HIV in the post-COVID era.
    Soriano V; Moreno-Torres V; Mendoza C; Corral O; Barreiro P
    AIDS Rev; 2023; 25(1):1-13. PubMed ID: 36952663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation.
    Toka B; Koksal AS; Eminler AT; Tozlu M; Uslan MI; Parlak E
    Dig Dis Sci; 2021 Jul; 66(7):2417-2426. PubMed ID: 32729014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.